Stocks and Investing Stocks and Investing
Wed, April 10, 2024

Charles Duncan Reiterated (ACAD) at Buy and Held Target at $37 on, Apr 10th, 2024


Published on 2024-10-28 10:14:42 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Reiterated "ACADIA Pharmaceuticals Inc." (ACAD) at Buy and Held Target at $37 on, Apr 10th, 2024.

Charles has made no other calls on ACAD in the last 4 months.



There are 15 other peers that have a rating on ACAD. Out of the 15 peers that are also analyzing ACAD, 5 agree with Charles's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jay Olson of "Oppenheimer" Maintained at Hold with Decreased Target to $19 on, Tuesday, March 12th, 2024
  • Uy Ear of "Mizuho" Downgraded from Strong Buy to Hold and Decreased Target to $25 on, Tuesday, March 12th, 2024
  • Tazeen Ahmad of "B of A Securities" Maintained at Hold with Decreased Target to $30 on, Tuesday, March 12th, 2024
  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $27 on, Monday, December 18th, 2023
  • Neena Bitritto-Garg of "Deutsche Bank" Downgraded from Strong Buy to Hold and Held Target at $25 on, Thursday, December 14th, 2023


These are the ratings of the 10 analyists that currently disagree with Charles


  • Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $32 on, Tuesday, April 9th, 2024
  • Tessa Romero of "JP Morgan" Maintained at Buy with Decreased Target to $25 on, Monday, March 25th, 2024
  • Jeffrey Hung of "Morgan Stanley" Maintained at Buy with Decreased Target to $30 on, Wednesday, March 13th, 2024
  • Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $31 on, Tuesday, March 12th, 2024
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $33 on, Tuesday, March 12th, 2024
  • David Hoang of "Citigroup" Maintained at Strong Buy with Decreased Target to $30 on, Tuesday, March 12th, 2024
  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $30 on, Tuesday, March 12th, 2024
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $39 on, Tuesday, March 12th, 2024
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $33 on, Tuesday, March 12th, 2024
  • Joseph Stringer of "Needham" Upgraded from Hold to Strong Buy and Held Target at $37 on, Wednesday, January 24th, 2024
Contributing Sources